Alteration of the dismal natural history of fibrosing cholestatic hepatitis secondary to hepatitis B virus with the use of lamivudine

Transplantation

Volumn 64, Issue 6, 1997, Pages 926-928

  Al Faraidy, Khalid ^a   Yoshida, Eric M ^a,b   Davis, Jennifer E ^a   Vartanian, Robert K ^a   Anderson, Frank H ^a   Steinbrecher, Urs P ^a,b,c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b British Columbia Transplant Society   (Canada)

^c VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; FOSCARNET; GANCICLOVIR; LAMIVUDINE; PREDNISONE;

ARTICLE; ASCITES; CASE REPORT; CHOLESTATIC HEPATITIS; DIABETIC NEPHROPATHY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; JAUNDICE; KIDNEY TRANSPLANTATION; LIVER FIBROSIS; LIVER TRANSPLANTATION; MALE; ORAL DRUG ADMINISTRATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; REINFECTION;

ANTIVIRAL AGENTS; CHOLESTASIS, INTRAHEPATIC; DIABETIC NEPHROPATHIES; DNA, VIRAL; GRAFT SURVIVAL; HEPATITIS B; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LAMIVUDINE; LIVER; LIVER FUNCTION TESTS; LIVING DONORS; MALE; MIDDLE AGED; RECURRENCE; TRANSPLANTATION, HOMOLOGOUS; VIRUS REPLICATION;

EID: 0030862080     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199709270-00024     Document Type: Article

References (19)

1. Davies SE, Portmann BC, O'Grady JG, et al. Hepatic histologic findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis. Hepatology 1991; 13: 150.
2. Walker N, Apel R, Kerlin P, et al. Hepatitis B virus infection in liver allografts. Am J Surg Pathol 1993; 17: 666.
3. Lam PWY, Wachs ME, Somberg KA, et al. Fibrosing cholestatic hepatitis in renal transplant recipients. Transplantation 1996; 61: 378.
4. Fornairon S, Pol S, Legendre C, et al. The long-term virologic and pathologic impact of renal transplantation on chronic hepatitis B virus infection. Transplantation 1996; 62: 297.
5. McIvor C, Morton J, Bryant A, et al. Fatal reactivation of precore mutant hepatitis B virus associated with fibrosing cholestatic hepatitis after bone marrow transplantation. Ann Intern Med 1994; 121: 274.
6. Fang JWS, Wright TL, Lau JYN. Fibrosing cholestatic hepatitis in patient with HIV and hepatitis B [letter]. Lancet 1993; 342: 1175.
7. Dickson RC, Caldwell SH, Ishitani MB, et al. Clinical and histologic patterns of early graft failure due to recurrent hepatitis C in four patients after liver transplantation. Transplantation 1996; 61: 701.
8. Angus P, Richards M, Bowden S, et al. Combination antiviral therapy controls severe post-liver transplant recurrence of hepatitis B virus infection. J Gastroenterol Hepatol 1992; 8: 353.
9. Jamal H, Regenstein F, Farr G, Perrillo RP. Prolonged survival in fibrosing cholestatic hepatitis with long-term ganciclovir therapy. Am J Gastroenterol 1996; 91: 1027.
10. Mason AL, Wick M, White HM, et al. Increased hepatocyte expression of hepatitis B virus transcription in patients with features of fibrosing cholestatic hepatitis. Gastroenterology 1993; 105: 237.
11. Lau JYN, Bain VG, Davies SE, et al. High-level expression of hepatitis B viral antigens in fibrosing cholestatic hepatitis: evidence that HBV may be cytopathic in liver grafts. Gastroenterology 1992; 102: 956.
12. Yoshida EM, Wolber RA, Mahmood WA, et al. Attempted resolution of acute recurrent hepatitis B in a transplanted liver allograft by the administration of ganciclovir. Transplantation 1994; 58: 956.
13. Gish RG, Lau JY, Brooks, et al. Ganciclovir treatment of hepatitis B virus infection in transplant recipients. Hepatology 1996; 23: 1.
14. Sherker AH, Hirota K, Omata M, Okuda K. Foscarnet decreases serum and liver duck hepatitis B virus DNA in chronically infected ducks. Gastroenterology 1986; 91: 818.
15. Dienstag JL, Perrillo RP, Schiff ER, et al. A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 1995; 333: 1657.
16. Benhamou Y, Katlama C, Lunel F, et al. Effects of lamivudine on replication of hepatitis B virus in HIV-infected men. Ann Intern Med 1996; 125: 705.
17. Grellier L, Mutimer D, Ahmed M, et al. Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. Lancet 1996; 348: 1212.
18. Bain VG, Kneteman NM, Ma MM, et al. Efficacy of lamivudine in chronic hepatitis B patients with active replication and decompensated cirrhosis undergoing liver transplantation. Transplantation 1996; 62: 1456.
19. Bartholomew MM, Jansen RW, Jeffers LJ, et al. Hepatitis-B-virus resistance to lamivudine given for recurrent infection after liver transplantation. Lancet 1997; 349: 20.